AcuityMD Raises $80M Series C Led by StepStone Group

Why It Matters

The infusion of $80 million enables AcuityMD to scale AI‑driven sales intelligence, sharpening market‑entry strategies for MedTech firms and accelerating adoption of advanced analytics across the industry.

Key Takeaways

• $80M Series C led by StepStone, valuation $955M.
• Platform serves 400+ MedTech firms, 16 of top 20.
• AcuityAI agentic AI offers instant territory and market insights.
• Customers identified $34B pipeline using AcuityMD data.
• Funding will expand AI agents, ontology depth, lifecycle support.

Pulse Analysis

MedTech sales teams face a fragmented data landscape, juggling claims databases, FDA filings, and shifting reimbursement rules. Traditional CRM tools struggle to synthesize this information quickly enough to inform territory planning. By building a proprietary ontology that unifies disparate data sources, AcuityMD creates a contextual knowledge graph that gives sales reps a single source of truth. This approach mirrors broader trends where niche AI platforms outpace generic models by embedding industry‑specific semantics, delivering higher relevance and faster decision cycles.

The launch of AcuityAI marks a shift from static analytics to agentic AI that can answer complex, ad‑hoc queries in seconds. Sales leaders can now ask the system to prioritize physicians, forecast market shifts, or generate actionable business plans without manual research. Early adopters report that insights which previously required hours of analysis are now delivered at the point of action, accelerating pipeline creation and shortening sales cycles. This capability translates into tangible revenue impact, as evidenced by the $34 billion of projected pipeline the platform has helped uncover for its customers.

The $80 million funding round underscores investor confidence in AI‑enabled go‑to‑market solutions for high‑stakes sectors like medical technology. With a near‑$1 billion valuation, AcuityMD is positioned to deepen its data model, develop specialized AI agents for marketing and leadership, and broaden its reach beyond commercial execution to support research, development, and product launch phases. As MedTech firms increasingly seek end‑to‑end digital transformation, platforms that combine robust ontologies with real‑time AI insights are likely to become indispensable, reshaping how new medical innovations are brought to market.

Deal Summary

AcuityMD, a MedTech sales intelligence platform, announced an $80 million Series C round led by StepStone Group, with participation from Benchmark, Redpoint Ventures, ICONIQ and Atreides Management. The funding brings total capital raised to over $160 million and values the company at $955 million. The proceeds will accelerate the rollout of its Agentic AI platform and expand support across the full product lifecycle.